In the constantly evolving field of medicine, innovation often arises from the gaps left by traditional solutions. Dr. Geoffrey Gurtner, a renowned surgeon-scientist, embodies this pursuit of innovation, amassing over 50 patents and impacting countless lives. His contributions have recently been acknowledged by the National Academy of Medicine, which recognized his groundbreaking work with one of its highest honors.
Dr. Gurtner, who holds the position of professor and chair at the Department of Surgery at the University of Arizona College of Medicine – Tucson, is among the 100 new inductees into the National Academy of Medicine. This prestigious institution collaborates with the National Academy of Sciences and the National Academy of Engineering, providing impartial guidance on health, science, and policy. Dr. Gurtner is now part of an elite group of seven faculty members from the University of Arizona to achieve this distinction.
“It’s obviously a huge honor, and I’m very grateful to have earned the respect of my peers and be elected to this,” expressed Gurtner, who is also associated with the biomedical engineering department and a member of the U of A Cancer Center.
Dr. Gurtner’s illustrious career includes receiving over $50 million in federal research funding, founding five venture capital-backed life science companies, and contributing to over 400 peer-reviewed articles. His leadership roles in various medical societies further underscore his influence in the field.
Dean of the College of Medicine – Tucson, Dr. Michael M.I. Abecassis, remarked, “Dr. Gurtner’s election to the National Academy of Medicine is a tremendous and well-deserved honor. His research and leadership have advanced how we care for patients and we are thrilled to see him recognized among the nation’s most distinguished leaders in medicine. This honor speaks to the caliber of faculty leading the College of Medicine – Tucson.”
Passionate about addressing unresolved medical challenges, Dr. Gurtner has dedicated his career to advancing innovations from the laboratory to patient care. He emphasized, “As a surgeon, I’m very interested in developing technology for areas where we don’t have great tools right now… But my interest has always been going quickly from the lab into first-in-man clinical trials and FDA approval, just to get things into patients in areas of unmet need.”
One of his lab’s pioneering projects is the “smart bandage,” a device equipped with artificial intelligence to preemptively detect infections. Supported by the Department of Defense and tested at Banner – University Medical Center Tucson, this project was recently chosen for funding through the Big Ideal Challenge, aimed at securing FDA approval.
Reflecting on his career path, Dr. Gurtner noted that traditional academic expectations often involved handing over discoveries for further development, a notion he eschewed. “I’ve tried to push through in the traditional physician and surgeon-scientist pathway,” he stated. “After plugging away for the past twenty-some years, to be recognized is very affirming.”
Dr. Gurtner aspires that this recognition will underscore the importance of translational and entrepreneurial pursuits in academia. “Hopefully, this honor will be external validation that might make presidents and provosts and deans more comfortable saying, ‘This a little different than the classic tripartite mission (clinical, research, education) but it has some value to the medical community, and maybe we should continue to pursue it.'”
Read More Here
Comments are closed.